9.00Open9.00Pre Close0 Volume1 Open Interest25.00Strike Price0.00Turnover0.00%IV-83.70%PremiumJul 19, 2024Expiry Date16.29Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.54Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Scholar Rock Stock Discussion
$AbbVie(ABBV.US)$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
$Protagonist Therapeutics(PTGX.US)$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis
$PTC Therapeutics(PTCT.US)$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022
$Scholar Rock(SRRK.US)$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Follow for more insights and top news for pharmacy industry! $The Health Care Select Sector SPDR® Fund(XLV.US)$ $Spdr Series Trust Spdr S&P Pharmaceuticals Etf(XPH.US)$ $Ishares Trust U.S. Pharmaceuticals Etf(IHE.US)$
• $Cowen(COWN.US)$ +14.4% ( $The Toronto-Dominion Bank(TD.US)$ is considering possible bid for COWN, according to Bloomberg)
• $Dyne Therapeutics(DYN.US)$ +11.1% (FDA lifts clinical hold, clears IND application to initiate clinical trial of DYNE-251)
• $OneConnect Financial Technology(OCFT.US)$ +10.8% (successfully lists on the Main Board of the Stock Exchange of Hong Kong)
• $Ring Energy(REI.US)$ +6.4% (acquires Stronghold's ...
$Mereo BioPharma(MREO.US)$ Mereo BioPharma shares are trading higher following reports suggesting AstraZeneca is weighing a bid for Mereo BioPharma.
$Seagen(SGEN.US)$ Seagen shares are trading higher following a WSJ report suggesting Merck and other unnamed suitors are eyeing a purchase of the company.
$Scholar Rock(SRRK.US)$ Schola...
geliyor gelmekte olan yırtıcılar
No comment yet